PDMR Shareholding/Share Incentive Plan and TVR
Diaceutics PLC announced that on September 30, 2025, trustees of the Global Diaceutics plc 2020 Employee Benefit Trust purchased ordinary shares of £0.002 for Susanne Munksted, Jordan Clark, Nick Roberts, and Jillian Beggs under the company's Share Incentive Plan. These purchases will continue monthly until further notice. The company matched these purchases with a 1:1 share award. The company issued 5,176 shares on October 1, 2025, to the UK Trust to settle matched share awards for UK PDMRs and other UK SIP Scheme participants. Each PDMR purchased 91 shares at a price of 165 pence, and received a matched share award of 91 shares at nil pence. Diaceutics has 84,885,572 shares in issue.
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
New York, Belfast and London, 1 October 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, has been notified that on 30 September 2025, Global Shares Trustees (UK) Limited (the "UK Trust") and Zedra Trust Company (Guernsey) Limited, the trustees of the Global Diaceutics plc 2020 Employee Benefit Trust, have purchased ordinary shares of £0.002 in the capital of the Company ("Shares") on behalf of Susanne Munksted, Jordan Clark, Nick Roberts and Jillian Beggs (PDMRs), in respect of their purchase of Shares pursuant to the Company's UK and Global Share Incentive Plan ("the SIP Schemes") for employees. These purchases will be made each month until further notice.
As announced on 2 October 2023, application was made to AIM for a block listing of 1,500,000 Shares to facilitate the admission of the Shares to trading following the exercise of options inter alia under the SIP Schemes. Therefore, the matched share awards for the UK PDMRs, along with those for all other participants in the UK SIP Scheme, have been settled by the Company issuing 5,176 Shares on 1 October 2025 to the UK Trust. The Trust will hold these Shares on behalf of participants until they vest in accordance with the UK Scheme rules.
Diaceutics has 84,885,572 Shares in issue. This figure may be used by shareholders in the Company as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
| a. | Name | Susanne Munksted |
| 2 | Reason for notification | |
| a. | Position/Status | Chief Precision Medicine Officer |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £ 0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Ongoing non-discretionary purchase of Shares matched by the grant of conditional share award over Shares under the Global Share Incentive Plan ("SIP") |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| 165 p | 91 | |
| Conditional share award: | ||
| Price(s) | Volume(s) | |
| Nil | 91 | |
| f. | Place of the transaction | Share Purchase: AIM Market of the London Stock Exchange Conditional share award: Off-Market |
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a. | Name | Jordan Clark |
| 2 | Reason for notification | |
| a. | Position/Status | Chief Data Officer |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £ 0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Ongoing non-discretionary purchase of Shares matched by the grant of conditional share award over Shares under the Diaceutics plc UK Share Incentive Plan ("SIP") |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| 165 p | 91 | |
| Matched share award: | ||
| Price(s) | Volume(s) | |
| Nil | 91 | |
| f. | Place of the transaction | Share Purchase: AIM Market of the London Stock Exchange Matched Share Award: Off-Market |
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a. | Name | Nick Roberts |
| 2 | Reason for notification | |
| a. | Position/Status | Chief Finance Officer |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £ 0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Ongoing non-discretionary purchase of Shares matched by the grant of conditional share award over Shares under the Diaceutics plc UK Share Incentive Plan ("SIP") |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| 165 p | 91 | |
| Matched share award: | ||
| Price(s) | Volume(s) | |
| Nil | 91 | |
| f. | Place of the transaction | Share Purchase: AIM Market of the London Stock Exchange Matched Share Award: Off-Market |
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a. | Name | Jillian Beggs |
| 2 | Reason for notification | |
| a. | Position/Status | Chief Commercial Officer |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £ 0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Ongoing non-discretionary purchase of Shares matched by the grant of conditional share award over Shares under the Diaceutics plc UK Share Incentive Plan ("SIP") |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| 165 p | 91 | |
| Matched share award: | ||
| Price(s) | Volume(s) | |
| Nil | 91 | |
| f. | Place of the transaction | Share Purchase: AIM Market of the London Stock Exchange Matched Share Award: Off-Market |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.